Published in Rheumatol Int on July 26, 2016
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum (1984) 20.51
Ankylosing spondylitis. Lancet (2007) 6.58
Ankylosing spondylitis: an overview. Ann Rheum Dis (2002) 2.71
Destructive lesions of vertebral bodies in ankylosing spondylitis. Ann Rheum Dis (1972) 2.59
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol (1999) 2.21
Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum (2007) 1.56
Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis (2005) 1.51
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis (2011) 1.46
Spinal fractures complicating ankylosing spondylitis. A long-term followup study. Arthritis Rheum (1983) 1.41
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum (2005) 1.41
MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis (2007) 1.40
Spinal changes in patients with spondyloarthritis: comparison of MR imaging and radiographic appearances. Radiographics (2005) 1.16
Spondylodiscitis in ankylosing spondylitis, inflammation or trauma? A description of six cases. Scand J Rheumatol (1996) 1.11
Aseptic discitis in patients with ankylosing spondylitis: a retrospective study of 14 cases. Joint Bone Spine (2005) 1.10
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol (2007) 1.08
Erosive vertebral disease in ankylosing spondylitis. Ann Phys Med (1968) 1.05
The epidemiology of spondylodiscitis in ankylosing spondylitis--a controlled study. Br J Rheumatol (1996) 0.99
Discovertebral destruction in ankylosing spondylitis: the role of computed tomography and magnetic resonance imaging. Br J Radiol (1990) 0.90
Early histology in ankylosing spondylitis related spondylodiscitis supports its inflammatory origin. Scand J Rheumatol (2005) 0.88
Pseudoarthrosis in ankylosing spondylitis mimicking infectious diskitis: MR appearance. AJNR Am J Neuroradiol (1992) 0.88
Opinion: Perspectives on imaging in axial spondyloarthritis. Nat Rev Rheumatol (2013) 0.87
Lessons learned from cervical pseudoarthrosis in ankylosing spondylitis. Eur Spine J (2005) 0.87
Magnetic resonance imaging of the axial skeleton in rheumatoid disease. Best Pract Res Clin Rheumatol (2004) 0.87
Destructive vertebral lesions in ankylosing spondylitis. Br J Radiol (1975) 0.85
Spondylodiscitis in ankylosing spondylitis: variable presentations. J Rheumatol (1983) 0.84
Variable histopathology of discovertebral lesion (spondylodiscitis) of ankylosing spondylitis. Clin Exp Rheumatol (1990) 0.82
The diagnostic utility of MRI in spondyloarthritis. Best Pract Res Clin Rheumatol (2012) 0.81
Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography. Clin Rheumatol (2010) 0.80
[Clinical value of MR tomography of spondylodiscitis in ankylosing spondylitis]. Z Rheumatol (1991) 0.79
Spinal changes in patients with ankylosing spondylitis on MRI: case series. J Pak Med Assoc (2010) 0.79
The Andersson lesion in ankylosing spondylitis: distinguishing between the inflammatory and traumatic subtypes. J Bone Joint Surg Br (2011) 0.77
Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages. Int J Mol Med (2017) 0.75
Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages. Int J Mol Med (2017) 0.75